Exciting times for obesity medicine as GLP-1 receptor agonists like Tirzepatide & Semaglutide have emerged as promising medications for weight loss, backed by compelling evidence from clinical trials.

When taking GLP-1 or GIP medications like Tirzepatide or Semaglutide maintaining a healthy diet is essential for optimizing their effectiveness and supporting overall health.

Individuals can expect several potential effects as their body adjusts to the medication.

The timeline for experiencing weight loss on GLP-1 medications can vary among individuals, but many people start to notice significant changes within the first few weeks to months of starting treatment.

Clinical studies investigating the role of Nicotinamide adenine dinucleotide (NAD+) supplementation in managing stress, anxiety, depression, and addiction have yielded intriguing findings.

Tirzepatide’s potential benefits for liver health are an area of active research.